Noile-Immune Biotech Inc. (TSE: 4893)
Health Care · Biotechnology · JP
¥94.00
-7.84% today · -42.3% 1Y
Noile-Immune Biotech Inc. (TSE: 4893) operates in the Biotechnology industry within the Health Care sector. The company is valued at $25.84M and employs 23 people.
Over the last twelve months the share price has lost 42.3%, trading between 89.00 and 217.00.
Tweenvest scores Noile-Immune Biotech Inc. across four factors: quality 40/100, value 11/100, growth 0/100. Its strongest factor is quality.
4893 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.84M
- Revenue (TTM)
- $6.15K
- P/E
- —
- EPS
- -17.41
- Dividend yield
- —
- Beta (5Y)
- 0.30
- 52-week high
- ¥217.00
- 52-week low
- ¥89.00
- Avg volume (3M)
- —
- Shares outstanding
- 43.40M
- Employees
- 23
- Next earnings
- —
About Noile-Immune Biotech Inc.
Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
- ISIN
- JP3759560000
- Founded
- 2015
- Listed since
- Jun 28, 2023
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| LabGenomics Co., Ltd.KOSDAQ: A084650 | $27.17M | ₩2,440.00 | -12.07% |
| Isofol Medical AB (publ)OM: ISOFOL | $26.73M | Skr0.83 | +3.51% |
| Kim Forest Enterprise Co., Ltd.TWSE: 6645 | $26.71M | NT$14.35 | +6.30% |
| Atossa Therapeutics, Inc.NasdaqCM: ATOS | $25.95M | $2.60 | -4.41% |
| Seoulin Bioscience Co.,Ltd.KOSDAQ: A038070 | $25.81M | ₩3,810.00 | -6.39% |
| Genesystem Co., Ltd.KOSDAQ: A363250 | $25.76M | ₩4,145.00 | +1.97% |
| Kainos Medicine, Inc.KOSDAQ: A284620 | $25.58M | ₩— | — |
| D. Western Therapeutics Institute, Inc.TSE: 4576 | $25.15M | ¥69.00 | -1.43% |
Figures last refreshed Oct 18, 2026.